Preparation and physicochemical characterizations of solid lipid nanoparticles containing DOTAPR ® for DNA delivery

Turkish Journal of Chemistry

Volumn 39, Issue 5, 2015, Pages 1012-1024

  Büyükköröglu, Gulay ^a   Yazan, Emine Yasemin ^a   Öner, Ayşe Filiz ^b  

^a ANADOLU UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Cationic solid lipid nanoparticles; Characterization; Colloidal carriers; DOTAPR; Gene delivery; Plasmid DNA; Preparation; SLN; Stability

Indexed keywords

EID: 84945205738     PISSN: 13000527     EISSN: 13036130     Source Type: Journal    
DOI: 10.3906/kim-1412-40     Document Type: Review

References (38)

1. Parhiza, H.; Shierb, W. T.; Ramezani, M. Int. J. Pharm. 2013, 457, 237-259.
2. Ibraheem, D.; Elaissari, A.; Fessi, H. Int. J. Pharm. 2014, 459, 70-83.
3. Duvall, C. L.; Prokop A.; Gersbach, C. A.; Davidson, J. M. In Principles of Tissue Engineering (Fourth Edition); Lanza, R.; Langer, R.; Vacanti, J. P., Eds. Elsevier: London, UK, 2014, pp. 687-723.
4. Büyükköroʇlu, G.; Abbasoʇlu, D.; H-zel, C. In Omics Approaches in Breast Cancer; Towards Next-Generation Diagnosis, Prognosis and Therapy; Barh, D., Ed. Springer: New Delhi, India, 2014, pp. 519-534.
5. Vighia, E.; Montanaria, M.; Hanuskovab, M.; Iannuccellia, V.; Coppia, G.; Leoa, E. Int. J. Pharm. 2013, 440, 161-169.
6. Worgall, S.; Crystal, R. G., Davidson, J. M. In Principles of Tissue Engineering (Fourth Edition); Lanza, R.; Langer, R.; Vacanti, J. P., Eds. Elsevier: London, UK, 2014, pp. 657-686.
7. Moreta, I.; Peris, J. E.; Guillema, V. M.; Beneta, M.; Reverta, F.; Dasi, F.; Crespoa, A.; Alino, S. F. J. Controlled Release 2001, 76, 169-181.
8. Saccardo, P.; Villaverde, A.; González-Montalbán, N. Biotechnol. Adv. 2009, 27, 432-438.
9. Woodle, M.; Scaria, P. Curr. Opin. Colloid Interface Sci. 2001, 6, 78-84.
10. Tros de Ilarduya, C.; Sun, Y.; Düzgüne-s, N. Eur. J. Pharma. Sci. 2010, 40, 159-170.
11. Zuidam, J. N.; Barenholz, Y. Biochim. Biophys. Acta 1998, 1368, 115-128.
12. Palmer, L. R.; Chen, T.; Lam, A. M. I.; Fenske, D. B.; Wong, K. F. Biochim. Biophys. Acta 2003, 1611, 204-216.
13. Olbrich, C.; Bakowsky, U.; Lehr, C. M.; Müller, R. H.; Kneuer, C. J. Controlled Release 2001, 77, 345-355.
14. Büyükköroʇlu, G.; Yazan, Y.; Öner, F. In Proceedings of 5th World Meeting on Pharmaceutics Biopharmaceutics and Pharmaceutical Technology, Geneva, Switzerland, 27-30 March 2006, p. 41.
15. Joshi, M. D.; Müller, R. H. Eur. J. Pharma. Biopharma. 2009, 71, 161-172.
16. Radomska-Soukharev, A. Adv. Drug Delivery Rev. 2007, 59, 411-418.
17. Fábregas, A.; Sánchez-Hernández, N.; Ticó, J. R.; García-Montoy, E.; Pérez-Lozano, P.; Suñé-Negre, J. M.; Hernández-Munain, C.; Suñé, C.; Minãrro, M. Int. J. Pharm. 2014, 473, 270-279.
18. Mehnert, W.; Mäder, K. Adv. Drug Delivery Rev. 2012, 64, 83-101.
19. Cortesi, R.; Campioni, M.; Ravani, L.; Drechsler, M.; Pinotti, M.; Esposito, E. New Biotechol. 2014, 31, 44-54.
20. Hou, D.; Xie, C. S.; Huang, K.; Zhu, C. H. Biomaterials 2003, 24, 1781-1785.
21. Cavalli, R.; Caputo, O.; Carlotti, M. E.; Trotta, M.; Scarnecchia, C.; Gasco, M. R. Int. J. Pharm. 1997, 148, 47-54.
22. Wissing, S. A.; Kayser, O.; Müller, R. H. Adv. Drug Delivery Rev. 2004, 56, 1257-1272.
23. Pardeike, J.; Weber, S.; Matsko, N.; Zimmer, A. Int. J. Pharm. 2012, 439, 22-27.
24. Kumar, S.; Randhawa, J. K. Mater. Sci. Eng. C. 2013, 33, 1842-1852.
25. Souto, E. B.; Wissing, S. A.; Barbosa, C. M.; Müller, R. H. Eur. J. Pharma. Biopharma. 2004, 58, 83-90.
26. Schwarz, C.; Mehnert, W.; Lucks, J. S.; Müller, R. H. J. Controlled Release 1994, 30, 83-96.
27. Bunjes, H.; Unruh, T. Adv. Drug Delivery Rev. 2007, 59, 379-402.
28. Jenning, V.; Thünemann, A. F.; Gohla, S. H. Int. J. Pharm. 2000, 199, 167-177.
29. Heurtault, B.; Saulnier, P.; Pech, B.; Proust, J. E. Biomaterials 2003, 24, 4283-4300.
30. Noack, A.; Hause, G.; Mädera, K. Int. J. Pharm. 2012, 423, 440-451.
31. Bunjes, H.; Koch, M. H. J. J. Controlled Release 2005, 107, 229-243.
32. Gaspar, V. M.; Correia, I. J.; Sousa, A.; Silva, F.; Paquete, C. M.; João, A.; Queiroz, A. J.; Sousa, F. J. Controlled Release 2011, 156, 212-222.
33. Huang, W.; Zhang, Z.; Han, X.; Tang, J.; Wang, J.; Dong, S.; Wang, E. Bioelectrochemistry 2003, 59, 21-27.
34. Mezei, A.; Pons, R.; Morán, M. C. Colloids Surf. B Biointerfaces 2013, 111, 663-671.
35. Mel'nikov, S. M.; Dias, R.; Mel'nikova, Y. S.; Marques, E. F.; Miguel, M. G.; Lindman, B. FEBS Lett. 1999, 453, 113-118.
36. Zuidam, N. J.; Barenholz, Y.; Minsky, A. FEBS Lett. 1999, 457, 419-422.
37. An, H.; Jin, B. Biotechnol. Adv. 2012, 30, 1721-1732.
38. Büyükköroʇlu, G.; Yazan, Y.; Öner, F. In Proceedings of European Conference on Drug Delivery and Pharmaceu-tical Technology Symposium, Seville, Spain, 2004, p. 133.